1. Home
  2. BUR vs SLNO Comparison

BUR vs SLNO Comparison

Compare BUR & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BUR
  • SLNO
  • Stock Information
  • Founded
  • BUR 2009
  • SLNO 1999
  • Country
  • BUR Guernsey
  • SLNO United States
  • Employees
  • BUR N/A
  • SLNO N/A
  • Industry
  • BUR Finance: Consumer Services
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • BUR Finance
  • SLNO Health Care
  • Exchange
  • BUR Nasdaq
  • SLNO Nasdaq
  • Market Cap
  • BUR 3.1B
  • SLNO 3.2B
  • IPO Year
  • BUR 2010
  • SLNO 2014
  • Fundamental
  • Price
  • BUR $12.86
  • SLNO $73.35
  • Analyst Decision
  • BUR Strong Buy
  • SLNO Strong Buy
  • Analyst Count
  • BUR 2
  • SLNO 9
  • Target Price
  • BUR $18.00
  • SLNO $103.33
  • AVG Volume (30 Days)
  • BUR 1.2M
  • SLNO 744.8K
  • Earning Date
  • BUR 05-07-2025
  • SLNO 05-07-2025
  • Dividend Yield
  • BUR 0.97%
  • SLNO N/A
  • EPS Growth
  • BUR N/A
  • SLNO N/A
  • EPS
  • BUR 0.93
  • SLNO N/A
  • Revenue
  • BUR $626,769,000.00
  • SLNO N/A
  • Revenue This Year
  • BUR $32.22
  • SLNO N/A
  • Revenue Next Year
  • BUR $6.31
  • SLNO N/A
  • P/E Ratio
  • BUR $13.79
  • SLNO N/A
  • Revenue Growth
  • BUR N/A
  • SLNO N/A
  • 52 Week Low
  • BUR $11.17
  • SLNO $36.93
  • 52 Week High
  • BUR $15.73
  • SLNO $80.99
  • Technical
  • Relative Strength Index (RSI)
  • BUR 38.79
  • SLNO 49.78
  • Support Level
  • BUR $12.83
  • SLNO $72.29
  • Resistance Level
  • BUR $13.26
  • SLNO $78.32
  • Average True Range (ATR)
  • BUR 0.34
  • SLNO 2.74
  • MACD
  • BUR -0.11
  • SLNO -0.57
  • Stochastic Oscillator
  • BUR 3.55
  • SLNO 27.11

About BUR Burford Capital Limited

Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

Share on Social Networks: